Omacetaxine for Consolidation and Maintenance

NCT01873495 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia (AML)

Interventions

DRUG: Omacetaxine

Sponsor

Emory University

Collaborators

[object Object]